| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |